The changing face of cardiovascular disease 2000–2012: An analysis of the world health organisation global health estimates data

International Journal of Cardiology

Volumn 224, Issue , 2016, Pages 256-264

  McAloon, Christopher J ^a,b   Boylan, Luke M ^b   Hamborg, Thomas ^b   Stallard, Nigel ^b   Osman, Faizel ^a   Lim, Phang B ^c   Hayat, Sajad A ^a  

^a UNIVERSITY HOSPITALS COVENTRY AND WARWICKSHIRE NHS TRUST   (United Kingdom)

^b UNIVERSITY OF WARWICK   (United Kingdom)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Cardiovascular disease; Epidemiology; Global burden of disease; World Health Organisation

Indexed keywords

AFRICAN; ALCOHOL CONSUMPTION; ATRIAL FIBRILLATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; CHINESE; CONGENITAL HEART DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DYSLIPIDEMIA; HEART FAILURE; HISPANIC; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; PHYSICAL ACTIVITY; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SOCIAL STATUS; SOUTH ASIAN; TOBACCO USE; WORLD HEALTH ORGANIZATION; CARDIOVASCULAR DISEASES; GLOBAL HEALTH; MORTALITY; STATISTICS; TRENDS;

CARDIOVASCULAR DISEASES; CAUSE OF DEATH; GLOBAL HEALTH; HUMANS; STATISTICS AS TOPIC; WORLD HEALTH ORGANIZATION;

EID: 84988355065     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2016.09.026     Document Type: Review

References (52)

1. [1] Mendis, S., Puska, P., Norrving, B., Global Atlas on Cardiovascular Disease Prevention and Control. 2011, World Health Organization.
2. [2] Moran, A.E., Roth, G.A., Narula, J., et al. 1990–2010 global cardiovascular disease atlas. Glob Heart 9:1 (2014), 3–16.
3. [3] Laslett, L.J., Alagona, P. Jr., Clark, B.A. 3rd, et al. The worldwide environment of cardiovascular disease: prevalence, diagnosis, therapy, and policy issues: a report from the American College of Cardiology. J. Am. Coll. Cardiol. 60:25 Suppl (2012), S1–49.
4. [4] World Health Organization, Global Health Estimates 2014 Summary Tables: Deaths by Cause, Age and Sex, by WHO Region, 2000–2012. http://www.who.int/healthinfo/global_burden_disease/en/, 2014 [Internet] Accessed: Monday 23rd March 2015, Available from.
5. [5] World Health Organization, Global Health Estimates 2014 Summary Tables: DALY by Cause, Age and Sex, by WHO Region, 2000–2012. http://www.who.int/healthinfo/global_burden_disease/en/, 2014 [Internet] Accessed: Saturday 18th April 2015, Available from.
6. [6] Fuster, V., Global burden of cardiovascular disease: time to implement feasible strategies and to monitor results. J. Am. Coll. Cardiol. 64:5 (2014), 520–522.
7. [7] World Health Organization, Global Health Estimates 2014 Summary Tables: Deaths by Cause, Age and Sex, by World Bank Region, 2000–2012. http://www.who.int/healthinfo/global_burden_disease/en/, 2014 [Internet] Accessed: Friday 3rd April 2015, Available from.
8. [8] World Health Organization, Global Health Estimated 2014 Summary Tables. http://www.who.int/healthinfo/global_burden_disease/en/, 2014 [Internet] Accessed: Sunday 5th April 2015, Available from.
9. [9] World Health Organization, International Statistical Classification of Diseases and Related Health Problems. 2004, World Health Organization.
10. [10] World Health Organization, WHO Methods and Data Sources for Country-level Causes of Death 2000–2012. Global Health Estimates Technical Paper WHO/HIS/HSI/GHE/2014.7, 2014, Department of Health Statistics and Information Systems, World Health Organization, Geneva.
11. [11] Pagidipati, N.J., Gaziano, T.A., Estimating deaths from cardiovascular disease: a review of global methodologies of mortality measurement. Circulation 127:6 (2013), 749–756.
12. [12] Modelmog, D., Rahlenbeck, S., Trichopoulos, D., Accuracy of death certificates: a population-based, complete-coverage, one-year autopsy study in East Germany. Cancer Causes Control 3:6 (1992), 541–546.
13. [13] Jha, P., Gajalakshmi, V., Gupta, P.C., et al. Prospective study of one million deaths in India: rationale, design, and validation results. PLoS Med., 3(2), 2006, e18.
14. [14] Murray, C.J., Ezzati, M., Flaxman, A.D., et al. GBD 2010: design, definitions, and metrics. Lancet 380:9859 (2012), 2063–2066.
15. [15] Baena, C.P., Chowdhury, R., Schio, N.A., et al. Ischaemic heart disease deaths in Brazil: current trends, regional disparities and future projections. Heart 99:18 (2013), 1359–1364.
16. [16] Moran, A., Forouzanfar, M., Sampson, U. et al., The epidemiology of cardiovascular diseases in sub-Saharan Africa: the Global Burden of Diseases, Injuries and Risk Factors 2010 Study Prog. Cardiovasc. Dis. 56:3 (2013), 234–239.
17. [17] World Health Organization, Global Health Estimates 2014 Summary Tables: DALY by Cause, Age and Sex, by World Bank Income Category and WHO Region 2000–2012. http://www.who.int/healthinfo/global_burden_disease/en/, 2014 [Internet] Accessed: Monday 11th May 2015. Available from.
18. [18] Nascimento, B.R., Brant, L.C.C., Moraes, D.N., et al. Global health and cardiovascular disease. Heart 100:22 (2014), 1743–1749.
19. [19] Alwan, A., Global Status Report on Noncommunicable Diseases 2010. 2011, World Health Organization.
20. [20] Kearney, P.M., Whelton, M., Reynolds, K., et al. Global burden of hypertension: analysis of worldwide data. Lancet, 365(9455), 2005, 217.
21. [21] Wild, S., Roglic, G., Green, A., et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:5 (2004), 1047–1053.
22. [22] World Health Organization, WHO Report on the Global Tobacco Epidemic, 2011: Warning about the Dangers of Tobacco. 2011, World Health Organization, Geneva.
23. [23] World Health Organization, UNAIDS. Prevention of Cardiovascular Disease. 2007, World Health Organization.
24. [24] World Health Organization, Global Health Risks: Mortality and Burden of Disease Attributable to Selected Major Risks. 2009, World Health Organization.
25. [25] Yusuf, S., Hawken, S., Ounpuu, S., et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case–control study. Lancet 364:9438 (2004), 937–952.
26. [26] Sattelmair, J., Pertman, J., Ding, E.L., et al. Dose response between physical activity and risk of coronary heart disease a meta-analysis. Circulation 124:7 (2011), 789–795.
27. [27] Moran, A.E., Forouzanfar, M.H., Roth, G.A., et al. The global burden of ischemic heart disease in 1990 and 2010: the Global Burden of Disease 2010 Study. Circulation 129:14 (2014), 1493–1501.
28. [28] Lopez, A.D., Murray, C., The global burden of disease. Nat. Med. 4:11 (1998), 1241–1243.
29. [29] Britton, A., McKee, M., The relation between alcohol and cardiovascular disease in Eastern Europe: explaining the paradox. J. Epidemiol. Community Health 54:5 (2000), 328–332.
30. [30] Chenet, L., McKee, M., Leon, D., et al. Alcohol and cardiovascular mortality in Moscow; new evidence of a causal association. J. Epidemiol. Community Health 52:12 (1998), 772–774.
31. [31] Yusuf, S., Reddy, S., Ounpuu, S., et al. Global burden of cardiovascular diseases: part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation 104:23 (2001), 2855–2864.
32. [32] Artaud-Wild, S.M., Connor, S.L., Sexton, G., et al. Differences in coronary mortality can be explained by differences in cholesterol and saturated fat intakes in 40 countries but not in France and Finland. A paradox. Circulation 88:6 (1993), 2771–2779.
33. [33] Thorvaldsen, P., Asplund, K., Kuulasmaa, K., et al. Stroke incidence, case fatality, and mortality in the WHO MONICA project. World Health Organization monitoring trends and determinants in cardiovascular disease. Stroke 26:3 (1995), 361–367.
34. [34] Chen, Z., Peto, R., Collins, R., et al. Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations. BMJ 303:6797 (1991), 276–282.
35. [35] World Health Organization, Global Health Estimates 2014 Summary Tables: Estimated Deaths (’000) by Cause, Sex and WHO Member State. http://www.who.int/healthinfo/global_burden_disease/en/, 2014 [Internet] Accessed: Friday 1st May 2015, Available from.
36. [36] Baker, J., Mitchell, R., Lawson, K., et al. Ethnic differences in the cost-effectiveness of targeted and mass screening for high cardiovascular risk in the UK: cross-sectional study. Heart 99:23 (2013), 1766–1771.
37. [37] Passel, J.S., Cohn, D., Lopez, M.H., Hispanics Account for More than Half of nation's Growth in Past Decade. 2011, Pew Hispanic Center http://pewhispanic.org/files/reports/140.pdf.
38. [38] Murray, C.J., Barber, R.M., Foreman, K.J., et al. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition. Lancet, 2015.
39. [39] World Health Organization, Life Expectancy: Data by WHO Region. http://apps.who.int/gho/data/view.main.690?lang=en, 2014 [Internet] Accessed: Tuesday 12th May 2015. Available from.
40. [40] Berrios, X., Koponen, T., Huiguang, T., et al. Distribution and prevalence of major risk factors of noncommunicable diseases in selected countries: the WHO Inter-Health Programme. Bull. World Health Organ. 75:2 (1997), 99–108.
41. [41] Lip, G.Y.H., Brechin, C.M., Lane, D.A., The global burden of atrial fibrillation and stroke: a systematic review of the epidemiology of atrial fibrillation in regions outside North America and Europe. Chest 142:6 (2012), 1489–1498.
42. [42] Miyasaka, Y., Barnes, M.E., Gersh, B.J., et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 114:2 (2006), 119–125.
43. [43] Lip, G.Y., Bawden, L., Hodson, R., et al. Atrial fibrillation amongst the Indo-Asian general practice population. The West Birmingham Atrial Fibrillation Project. Int. J. Cardiol. 65:2 (1998), 187–192.
44. [44] Rahman, F., Kwan, G.F., Benjamin, E.J., Global epidemiology of atrial fibrillation. Nat. Rev. Cardiol. 11:11 (2014), 639–654.
45. [45] Mendez, G.F., Cowie, M.R., The epidemiological features of heart failure in developing countries: a review of the literature. Int. J. Cardiol. 80:2–3 (2001), 213–219.
46. [46] Morillo, C., Marin-Neto, J., Avezum, A., et al. Randomized trial of benznidazole for chronic Chagas’ cardiomyopathy. N. Engl. J. Med. 373 (2015), 1295–1306.
47. [47] Bocchio, E., Heart failure in South America. Curr. Cardiol. Rev. 9:2 (2013), 147–156.
48. [48] Ambrosy, A.P., Fonarow, G.C., Butler, J., et al. The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. J. Am. Coll. Cardiol. 63:12 (2014), 1123–1133.
49. [49] Cowie, M.R., Wood, D.A., Coats, A.J., et al. Survival of patients with a new diagnosis of heart failure: a population based study. Heart 83:5 (2000), 505–510.
50. [50] Mehta, P.A., Dubrey, S.W., McIntyre, H.F., et al. Improving survival in the 6 months after diagnosis of heart failure in the past decade: population-based data from the UK. Heart 95:22 (2009), 1851–1856.
51. [51] Stewart, S., Horowitz, J.D., Home-based intervention in congestive heart failure: long-term implications on readmission and survival. Circulation 105:24 (2002), 2861–2866.
52. [52] Hoffman, J., The global burden of congenital heart disease. Cardiovasc. J. Afr. 24:4 (2013), 141–145.